Conference abstract · 12 Sep 2016
Review articlePublished 2016
Is Cardiac Stem Cell Therapy a New Horizon of Heart Regeneration: Literature Review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Improvements in the care of patients with cardiovascular disease have led to improved survival but also a burgeoning population of patients with advanced heart disease. Cardiac stem cells (CSC) continue to promise opportunities to repair damaged cardiac tissue. However, precisely how stem cells accomplish cardiac repair, especially after ischemic damage, remains controversial. It has been postulated that the clinical benefit of adult stem cells for cardiovascular disease results from the release of cytokines and growth factors by the transplanted cells, stimulation of new blood vessel growth, enhancing tissue perfusion, and via preservation or even regeneration of myocardial tissue, leading to improvements in cardiac performance after myocardial infarction and in patients with advanced heart failure, reducing inflammation, and scar formation, as well as protecting cardiomyocytes from apoptosis. In addition, reducing fibrosis these factors might also stimulate endogenous repair by activating cardiac stem cells. Interestingly, stem cells discovered to be resident in the heart appear to be functionally superior to extra-cardiac adult stem cells when transplanted for cardiac repair and regeneration. Stem cells are the seeds of tissue repair and regeneration and a promising source for novel therapies. However, apart from hematopoietic stem cell (HSC) transplantation, all other stem cell treatments yet remain experimental. Mounting hopes have encouraged numerous clinical trials, but it has been difficult to obtain unequivocal evidence for robust clinical benefit. This review provides a historic framework and an abridgment of how the theories of CSC origin and potential evolved from early times to the present day. The development of more effective cardiac therapies may thus require targeting this important cell population. Here, we summarize and offer some thoughts on the state of the field of cell therapy for ischemic heart diseases and the therapeutic potential of cardiac stem cells.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Perspective · 11 Aug 2023
An Overview of Cardiac Regeneration by Stem Cells
Commentary · 2014
Bioengineering for Stem Cell-Based Cardiac Regeneration
Conference abstract
Use of electro stimulation as a ?Clean? method for stem cell's differentiation and cardiac tissue regeneration
Opinion · 4 Aug 2023
Exploring Cardiac Progenitor Stem Cells as a Treatment for Heart Restoration
More from this journal
The newest in Molecular Biology: Open Access.
Brief report · 29 Dec 2025
Molecular Foundations of Cellular Life: Mechanisms and Dynamics
Commentary · 29 Dec 2025
Molecular Insights: Advancing Biology and Therapeutics
Brief report · 29 Dec 2025
Advancing Molecular Visualization and Understanding
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMolecular Biology: Open Access
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Mohammad Afaque Alam”
- BylineArticles whose byline prints “Muhammad Fawad Ishfaq”
- BylineArticles whose byline prints “Bushra Khanam”

